Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Horizon Space Acquisition I
Acquired Company
ArcheNova Biotech
Cayman IslandsAerospaceManufacturingBiotechnologyBiopharmaDescription
Horizon Space Acquisition I Corp. has signed a definitive agreement to merge with ArcheNova Biotech, aiming for the combined company to be listed on Nasdaq. The closing of the merger is anticipated in Q1 2027, pending necessary approvals and conditions. This merger marks a significant step for both companies towards public market engagement.
Fundz sees it the moment Horizon Space Acquisition I makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired ArcheNova Biotech?
ArcheNova Biotech was acquired by Horizon Space Acquisition I. The deal was reported on October 13, 2026. Horizon Space Acquisition I Corp. is a special purpose acquisition company (SPAC) focused on merging with a business in the aerospace or technology sector. Horizon Space Acquisition I is privately held and operates in Aerospace.
When did Horizon Space Acquisition I acquire ArcheNova Biotech?
Horizon Space Acquisition I's acquisition of ArcheNova Biotech was reported on October 13, 2026. Horizon Space Acquisition I Corp. has signed a definitive agreement to merge with ArcheNova Biotech, aiming for the combined company to be listed on Nasdaq. The closing of the merger is anticipated in Q1 2027, pending necessary approvals and conditions. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does ArcheNova Biotech do?
ArcheNova Biotech Corp. is a clinical-stage biopharmaceutical company focused on developing innovative drugs from MSC-derived extracellular vesicles and exosomes. The company works on therapeutic programs in areas like dermatology and neurology. It is privately held, operating in Manufacturing, and is based in Cayman Islands.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.